Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis;Kann der einsatz megatherapie die prognose beim metastasierten Neuroblastom verbessern? Eine retrospektive analyse

Klinische Padiatrie

Volumn 209, Issue 4, 1997, Pages 196-200

  Hero, Barbara ^a   Kremens, Bernhard ^b   Klingebiel, Thomas ^c   Bender Götze, Christine ^d   Burdach, Stefan ^e   Schrappe, Martin ^f   Berthold, Frank ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e Children's Hospital of Universities   (Germany)

^f Children's Hospital of Universities   (Germany)

Author keywords

Megatherapy; Neuroblastoma; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; HUMAN; METASTASIS; NEUROBLASTOMA; TREATMENT OUTCOME;

EID: 0030802892     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043950     Document Type: Article

References (23)

1. August, S. C., F. T. Serota, P. A. Koch, E. Burkety, H. Schlesinger, W. L. Elkins, A. E. Evans, G. J. D'Angio: Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation and allogeneic or autologous marrow reconstitution. J. Clin. Oncol. 2 (1984) 609-616
2. Berthold, F., S. Burdach, B. Kremens, F. Lampert, D. Niethammer, H. Richm, J. Ritter, J. Treuner, S. Utsch, J. Zieschang: The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pedaitric oncology Society) experience. Klin. Pädiatr. 202 (1990) 262-269
3. Berthold, F., T. Trechow, S. Utsch, J. Zieschung: Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am. J. Pediatr. Hematol. Oncol. 14 (1942) 207-215
4. Brodeur, G. M., R. C. Seeger, A. Barrett, F. Berthold, R. P Castleberry, G. J. D'Angio, B. De Bernardi, A. E. Evans, M. Favrot, A. I. Freeman, G. Haase, O. Hartmann, F. A. Hayers, L. Helson, J. Kemshead, F. Lampert, J. Ninane, H. Ohkawa, T. Philip, C. R. Pinkerton, J. Pritchard, T. Sawada, S. Siegel, E. I. Smith, Y. Tsuchida, P. A. Voute: International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 6 (1988) 1874-1881
5. McElwain, T. J., D. W. Hedley, M. Y. Gordon, M. Jarman, J. L. Millar, J. Pritchard: High dose melphalan and non cryopreservcd autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp. Hem. 7 (1979) 360-371
6. Evans, A. E., C. S. August, N. Kamani, N. Bunin, J. Goldwein, A. J. Ross III. G. J. D'Angin: Bone marrow transplantation for high risk neuroblastoma at the Childrens's Hospital of Philadelphia: an update. Med. Ped. Oncol. 23 (1994) 323-327
7. Frapazz, D., J. M. Zucker, J. L. Bernard, J. Michon, C. Coze, M. Lopez, M. Favrot, A. Fourquet, B. Asselain, F. Chauvin, T. Philip: Single or double consolidation according to remission status after induction: LMCE3 study in 99 unselected NB > 1 year of age at diagnosis. Proceedings of Advances in Neuroblastoma Research, Philadelphia 1996
8. Kaplan, E. L., P. Meyer: Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
9. Kemshead, J. T., L. Heath, F. M. Gibson, F. Katz, F. Richmond, J. Tre-leaven, J. Ugelstad: Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from hone marrow: experiences, improvements and observations. Br. J. Cancer 54 (1986) 771-778
10. Kremens, B., V. Combaret, M. Favrot, J. C. Laurent, T. Philip: Evaluation eines modifizierten immunomagnetischen Verfahrens zur Entfernung von Neuroblastomzellen aus Knochenmark. Monatsschr. Kinderheilk. 138 (1990) 331-336
11. Kremens, B., B. Hero, M. Garte, M. Zimmermann, F. Berthold: Maintenance therapy versus megatherapy as consolidation treatment in stage 4 neuroblastoma. Med. Ped. Oncol. 27 (1996) 251 (Meeting abstract)
12. Ladenstein, R., P. F. Ambros, C. Urban, I. M. Ambros, F. M. Fink, A. Zoubek, H. Grienberger, K. Schmitt, R. Kerbl, E. Horcher, G. Amann, G. Höfler, H. Heinzl, H. Gadner, I. Mutz: Wertigkeit prognostischer Faktoren in der österreichischen A-NB87 Neuroblastom Studie. Klin. Padiatr. 208 (1996) 210-220
13. Matthay, K. K., M. C. O'Leary, N. K. Ramsay, J. Villablanca, C. P. Reynolds, J. B. Alkinson, G. M. Hause, D. O. Strum, R. C. Seeger: Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results. Eur. J. Cancer 31A (1995) 572-575
14. Ohnuma, N., H. Takahashi, M. Kaneko, J. Uchino, T. Takeda, M. Iwafuchi, M. Ohhira, H. Nishihira, H. Mugishima, J. Yokoyama, A. Okuda, N. Nagahara, N. Taguchi, Y. Tsuchida: Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the study group of Japan. Med. Ped. Oncol. 24 (1995) 181-187
15. Philip, E., J. L. Bernard, J. M. Zucker, R. Pinkerton, P. Lutz, P. Bordigoni, E. Plouvier, A. Robert, R. Carton, N. Philippe, I. Philip, F. Chauvin, M. Favrot: High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J. Clin. Oncol. 5 (1987) 266-271
16. Pinkerton, C. R.: ENSG 1-randomised study of high dose-melphalan in neuroblastoma. Bone Marrow Transplant. 7 (1991) 112-113 (suppl 3)
17. Pinkerton, C. R., T. Philip, P. Biron, D. Frapazz, N. Phillipe, J. M. Zucker, J. L. Bernard, I. Philip, J. Kemshead, M. Favrot: High-dose melphalan, vincristine and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study. Med. Ped. Oncol. 15 (1987) 236-240
18. Pritchard, J., T. J. McElwain, J. Graham-Pole: High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br. J. Cancer 45 (1982) 86-94
19. O'Reilly, R. J., B. H. Kashner, N.-K. V. Cheung, L. R. Mandell, F. Ghavimi, S. C. Gulatti, M. Sullivan, P. Exelby: Myeloablative combination chemotheray and local irradiation with autologous bone marrow rescue for neuroblastoma. Memorial Sloan-Kettering Cancer Center. New York, therapy protocol 87-56, 1987
20. Shuster, J. J.: The role of autologous bone marrow transplantation in advanced neuroblastoma. J. Clin. Oncol. 14 (1996) 2413-2414
21. Shuster, J. J., A. B. Cantor, N. McWilliams, J. Graham-Pole, R. P. Castleberry, R. Marcus, T. Pick, E. I. Smith, F. A. Hayes: The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J. Clin. Oncol. 9 (1991) 1045-1049
22. Stram, D. O., K. K. Matthay, M. O'Leary, C. P. Reynolds, G. M. Haase, J. B. Atkinson, G. M. Brodeur, R. C. Seeger: Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J. Clin. Oncol. 14 (1996) 2417-2426
23. Multizentrische Therapiestudie der Gesellschaft für Pädiatrische Onkologie zur Behandlung von Neuroblastomen bei Kindern und Jugendlichen (NB85).